These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 18079970)

  • 1. The MEF2D transcription factor mediates stress-dependent cardiac remodeling in mice.
    Kim Y; Phan D; van Rooij E; Wang DZ; McAnally J; Qi X; Richardson JA; Hill JA; Bassel-Duby R; Olson EN
    J Clin Invest; 2008 Jan; 118(1):124-32. PubMed ID: 18079970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of angiotensin II-mediated cardiac remodeling by the MEF2A target gene Xirp2.
    McCalmon SA; Desjardins DM; Ahmad S; Davidoff KS; Snyder CM; Sato K; Ohashi K; Kielbasa OM; Mathew M; Ewen EP; Walsh K; Gavras H; Naya FJ
    Circ Res; 2010 Mar; 106(5):952-60. PubMed ID: 20093629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adiponectin is required for cardiac MEF2 activation during pressure overload induced hypertrophy.
    Dadson K; Turdi S; Hashemi S; Zhao J; Polidovitch N; Beca S; Backx PH; McDermott JC; Sweeney G
    J Mol Cell Cardiol; 2015 Sep; 86():102-9. PubMed ID: 26196305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myocyte enhancer factors 2A and 2C induce dilated cardiomyopathy in transgenic mice.
    Xu J; Gong NL; Bodi I; Aronow BJ; Backx PH; Molkentin JD
    J Biol Chem; 2006 Apr; 281(14):9152-62. PubMed ID: 16469744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Requirement of protein kinase D1 for pathological cardiac remodeling.
    Fielitz J; Kim MS; Shelton JM; Qi X; Hill JA; Richardson JA; Bassel-Duby R; Olson EN
    Proc Natl Acad Sci U S A; 2008 Feb; 105(8):3059-63. PubMed ID: 18287012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TEAD-1 overexpression in the mouse heart promotes an age-dependent heart dysfunction.
    Tsika RW; Ma L; Kehat I; Schramm C; Simmer G; Morgan B; Fine DM; Hanft LM; McDonald KS; Molkentin JD; Krenz M; Yang S; Ji J
    J Biol Chem; 2010 Apr; 285(18):13721-35. PubMed ID: 20194497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted disruption of Hspa4 gene leads to cardiac hypertrophy and fibrosis.
    Mohamed BA; Barakat AZ; Zimmermann WH; Bittner RE; Mühlfeld C; Hünlich M; Engel W; Maier LS; Adham IM
    J Mol Cell Cardiol; 2012 Oct; 53(4):459-68. PubMed ID: 22884543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-talk between glycogen synthase kinase 3β (GSK3β) and p38MAPK regulates myocyte enhancer factor 2 (MEF2) activity in skeletal and cardiac muscle.
    Dionyssiou MG; Nowacki NB; Hashemi S; Zhao J; Kerr A; Tsushima RG; McDermott JC
    J Mol Cell Cardiol; 2013 Jan; 54():35-44. PubMed ID: 23137781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A state of reversible compensated ventricular dysfunction precedes pathological remodelling in response to cardiomyocyte-specific activity of angiotensin II type-1 receptor in mice.
    Frentzou GA; Drinkhill MJ; Turner NA; Ball SG; Ainscough JF
    Dis Model Mech; 2015 Aug; 8(8):783-94. PubMed ID: 26092119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MEF2 transcriptional activity maintains mitochondrial adaptation in cardiac pressure overload.
    el Azzouzi H; van Oort RJ; van der Nagel R; Sluiter W; Bergmann MW; De Windt LJ
    Eur J Heart Fail; 2010 Jan; 12(1):4-12. PubMed ID: 20023039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo.
    Passier R; Zeng H; Frey N; Naya FJ; Nicol RL; McKinsey TA; Overbeek P; Richardson JA; Grant SR; Olson EN
    J Clin Invest; 2000 May; 105(10):1395-406. PubMed ID: 10811847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MEF2 activates a genetic program promoting chamber dilation and contractile dysfunction in calcineurin-induced heart failure.
    van Oort RJ; van Rooij E; Bourajjaj M; Schimmel J; Jansen MA; van der Nagel R; Doevendans PA; Schneider MD; van Echteld CJ; De Windt LJ
    Circulation; 2006 Jul; 114(4):298-308. PubMed ID: 16847152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nrf2 enhances myocardial clearance of toxic ubiquitinated proteins.
    Wang W; Li S; Wang H; Li B; Shao L; Lai Y; Horvath G; Wang Q; Yamamoto M; Janicki JS; Wang XL; Tang D; Cui T
    J Mol Cell Cardiol; 2014 Jul; 72():305-15. PubMed ID: 24747945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Load-induced transcriptional activation of c-jun in rat myocardium: regulation by myocyte enhancer factor 2.
    Nadruz W; Kobarg CB; Constancio SS; Corat PD; Franchini KG
    Circ Res; 2003 Feb; 92(2):243-51. PubMed ID: 12574153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of myocardial retinoic acid receptor α induces diastolic dysfunction by promoting intracellular oxidative stress and calcium mishandling in adult mice.
    Zhu S; Guleria RS; Thomas CM; Roth A; Gerilechaogetu F; Kumar R; Dostal DE; Baker KM; Pan J
    J Mol Cell Cardiol; 2016 Oct; 99():100-112. PubMed ID: 27539860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the
    Sun Y; Wang Q; Fang Y; Wu C; Lu G; Chen Z
    Dis Model Mech; 2017 Oct; 10(10):1217-1227. PubMed ID: 28801532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac myocyte miR-29 promotes pathological remodeling of the heart by activating Wnt signaling.
    Sassi Y; Avramopoulos P; Ramanujam D; Grüter L; Werfel S; Giosele S; Brunner AD; Esfandyari D; Papadopoulou AS; De Strooper B; Hübner N; Kumarswamy R; Thum T; Yin X; Mayr M; Laggerbauer B; Engelhardt S
    Nat Commun; 2017 Nov; 8(1):1614. PubMed ID: 29158499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wnt signaling is critical for maladaptive cardiac hypertrophy and accelerates myocardial remodeling.
    Malekar P; Hagenmueller M; Anyanwu A; Buss S; Streit MR; Weiss CS; Wolf D; Riffel J; Bauer A; Katus HA; Hardt SE
    Hypertension; 2010 Apr; 55(4):939-45. PubMed ID: 20177000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Talin1 has unique expression versus talin 2 in the heart and modifies the hypertrophic response to pressure overload.
    Manso AM; Li R; Monkley SJ; Cruz NM; Ong S; Lao DH; Koshman YE; Gu Y; Peterson KL; Chen J; Abel ED; Samarel AM; Critchley DR; Ross RS
    J Biol Chem; 2013 Feb; 288(6):4252-64. PubMed ID: 23266827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy.
    Zhang CL; McKinsey TA; Chang S; Antos CL; Hill JA; Olson EN
    Cell; 2002 Aug; 110(4):479-88. PubMed ID: 12202037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.